Latest Manufacturing News

Evion Group has appointed former Australian Ambassador to the US, Arthur Sinodinos, as Strategic Advisor to accelerate its US critical minerals strategy following its acquisition of the CARP Fluorspar Project in Nevada.

Independent U.S. Army and WMTR testing confirms IperionX's Ti-6Al-4V fasteners outperform high-strength Grade 8 steel in torque-to-yield and tensile strength, underpinning a secure domestic titanium supply chain.

Little Green Pharma (ASX:LGP) has completed its merger with Cannatrek, creating a dominant player in Australia and Europe’s medicinal cannabis market with a majority stake held by former Cannatrek shareholders.

Flynn Gold has ramped up its diamond drilling program at the Firetower Gold-Tungsten Project in northern Tasmania, expanding from three to ten holes totalling 1,600 metres. The move aims to test high-grade extensions and support a maiden Mineral Resource Estimate amid critical mineral supply pressures.

ParagonCare anticipates recovering up to 32.5% of its exposure to the insolvent Infinity Retail Pharmacy Group, while maintaining a steady FY26 earnings outlook amid cost pressures.

BluGlass has locked in a $1 million firm commitment through an option shortfall agreement, with potential to raise $1.5 million, reinforcing its financial position after an upsized $8 million placement. The funds will accelerate GaN laser contract delivery and working capital.

Chimeric Therapeutics reports encouraging Phase 1/2 data for its CHM CDH17 CAR-T therapy in advanced gastrointestinal cancers, with 82% of evaluable patients achieving stable disease and durable responses lasting over a year.

FOS Capital, through its Aldridge Traffic Systems arm, has landed its largest contract to date, supplying advanced ITS lighting for a major Victorian freeway upgrade, lifting its order book to $9 million.

1414 Degrees has formed an Aerospace, Drone & Defence Advisory Board featuring six veterans from top defence and aerospace firms to accelerate the rollout of its SiNTL silicon anode battery technology targeting drones and adjacent markets.

Amplia Therapeutics reported encouraging mature data from its ACCENT pancreatic cancer trial showing improved survival and response rates with narmafotinib. The company raised $27.5 million to fund development and manufacturing scale-up, while discontinuing a parallel trial due to chemotherapy toxicity.

Papyrus Australia has secured a key milestone under its TBS Mining Contract by executing a board production deal with a Vietnam manufacturer, while raising $325,000 to support commercial scale-up and facility establishment.

PolyNovo has completed its pivotal US clinical trial report for NovoSorb BTM and adjusted its FDA Premarket Approval submission timeline to late 2026 to incorporate updated regulatory requirements and additional data.